Literature DB >> 5699931

Synchronized cell division in Tetrahymena pyriformis following inhibition with vinblastine.

G E Stone.   

Abstract

The ability of Tetrahymena pyriformis to undergo synchronous division following release of inhibition with vinblastine was examined. The degree of synchrony was shown to be correlated with the period of time spent under the influence of vinblastine. Cells were inhibited for different periods of time with vinblastine and then washed free of the inhibitor with fresh medium. The increase in cell number and division index was followed subsequent to release of inhibition. Inhibition for a period of time equal to about two generation times was required to produce a complete doubling of the population during the first division. Inhibition for longer periods of time resulted in the population's increasing by more than a factor of two during the first division burst. The nuclear cytology indicates that the micronucleus is probably blocked in mitosis.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5699931      PMCID: PMC2107553          DOI: 10.1083/jcb.39.3.556

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  13 in total

1.  ACUTE EFFECTS OF CYTOTOXIC COMPOUNDS ON INCORPORATION OF PRECURSORS INTO DNA, RNA, AND PROTEIN OF HELA MONOLAYERS.

Authors:  C W YOUNG; S HODAS
Journal:  Biochem Pharmacol       Date:  1965-03       Impact factor: 5.858

2.  The effect of vincaleukoblastine on dividing cells in vivo.

Authors:  J H CUTTS
Journal:  Cancer Res       Date:  1961-02       Impact factor: 12.701

3.  Studies on unbalanced growth in tissue culture. I. Induction and consequences of thymidine deficiency.

Authors:  R R RUECKERT; G C MUELLER
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

4.  DNA synthesis, phosphate content and growth in mass and volume in synchronously dividing cells.

Authors:  O H SCHERBAUM; A L LOUDERBACK; T L JAHN
Journal:  Exp Cell Res       Date:  1959-08       Impact factor: 3.905

5.  Antitumor principles derived from Vinca rosea Linn. I. Vincaleukoblastine and leurosine.

Authors:  I S JOHNSON; H F WRIGHT; G H SVOBODA; J VLANTIS
Journal:  Cancer Res       Date:  1960-08       Impact factor: 12.701

6.  Synchronous divisions in Tetrahymena pyriformis as studied in an inorganic medium; the effect of 2,4-dinitrophenol.

Authors:  K HAMBURGER; E ZEUTHEN
Journal:  Exp Cell Res       Date:  1957-12       Impact factor: 3.905

7.  The arrest of mitosis and stomatogenesis during temperature-induction of synchronous division in Tetrahymena pyriformis, mating type 1, variety 1.

Authors:  G G HOLZ; O H SCHERBAUM; N WILLIAMS
Journal:  Exp Cell Res       Date:  1957-12       Impact factor: 3.905

8.  Cell division and protein synthesis in Tetrahymena, as studied with p-fluorophenylalanine.

Authors:  L RASMUSSEN; E ZEUTHEN
Journal:  C R Trav Lab Carlsberg       Date:  1962

9.  The effect of nucleic acid antagonists on cell division and oral organelle development in Tetrahymena pyriformis.

Authors:  J Frankel
Journal:  J Exp Zool       Date:  1965-06

10.  Effects of vinblastine on the proliferative capacity of L cells and their progress through the division cycle.

Authors:  N Bruchovsky; A A Owen; A J Becker; J E Till
Journal:  Cancer Res       Date:  1965-09       Impact factor: 12.701

View more
  3 in total

1.  Antimitotic agents and macronuclear division of ciliates IV. Reassembly of microtubules in macronuclei of Tetrahymena adapting to colchicine.

Authors:  F Wunderlich; V Speth
Journal:  Protoplasma       Date:  1970       Impact factor: 3.356

2.  Transient neutropenia after intravenous injection of vindesine in patients with lung cancer.

Authors:  K Aoshiba; A Nagai; H Ueno; K Konno
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

3.  Inhibition of cilia regeneration of Tetrahymena by ansamitocins, new antitumor antibiotics.

Authors:  S Tanida; E Higashide; M Yoneda
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.